Curis (CRIS)
(Real Time Quote from BATS)
$1.67 USD
0.00 (0.00%)
Updated Aug 7, 2025 11:18 AM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRIS 1.67 0.00(0.00%)
Will CRIS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRIS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRIS
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
CRIS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline
Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates
Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates
Other News for CRIS
Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Q2 2025 Curis Inc Earnings Call Transcript
Curis, Inc. 2025 Q2 - Results - Earnings Call Presentation
Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript
Curis targets enrolling 30–40 additional patients for NDA and EMA submissions as emavusertib studies advance